For example, The Health Foundations’ March 2017 chart of the month plotted the cost of drugs for the NHS in England by sector and makes no mention of the difference between these statistics and ...

Source Reference: Ray A, et al "Glucose-lowering medications and risk of chronic obstructive pulmonary disease exacerbations in patients with type 2 diabetes" JAMA Intern Med 2025; DOI ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Dec. 18, 2024 — Until now, scientists have been unable to determine how metformin, a Type 2 diabetes medication that lowers blood sugar, works. A study provided direct evidence in mice that it ...

In most cases, your doctor will start by prescribing oral medication. Metformin is the first-line treatment for the majority of people with type 2 diabetes. Over time, you might need to add other ...

In addition to charts, medication order sheets and medication administration records (MARs) are reviewed daily. Voluntary and solicited reports are obtained from staff. Finally, additional sources ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Among patients with type 2 diabetes, use of GLP-1 agonists may increase the risks for adhesive capsulitis and required surgical intervention, such as manipulation under anesthesia, according to ...

“With NHS cancer services in crisis and around half a million new cancer cases each year expected by 2040 – this hard-won progress is at risk of stalling,” said CRUK, which is calling on all ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...